A carregar...
HSulf-1 and palbociclib exert synergistic antitumor effects on RB-positive triple-negative breast cancer
Human sulfatase-1 (HSulf-1) is emerging as a novel prognostic biomarker in breast cancer. Previous studies demonstrated HSulf-1 to function as a negative regulator of cyclin D1 in breast cancer. Accumulating preclinical evidence is supporting the efficacy of cyclin-dependent kinase (CDK) 4/6 inhibit...
Na minha lista:
| Publicado no: | Int J Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7252455/ https://ncbi.nlm.nih.gov/pubmed/32377705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5057 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|